About: Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1990 (uk) im März 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1990 (ast) scientific article published on 01 March 1990 (en)
publication date	wds:Q68931996-97F4BF14-56C6-4F08-ACA1-1CCD9B86ADDC
publication date	1990-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68931996-695D2AA8-C018-4F96-817B-E9EBF33BBCBE
language of work or name	English
author name string	wds:Q68931996-0238C9B8-5879-46A3-BDFA-A731350E970F wds:Q68931996-33A312ED-9EF8-4E02-8011-1556557C98F4 wds:Q68931996-6FED301F-EA2A-4E85-846C-38EE0C6BEEA9 wds:Q68931996-B04B8D33-46DB-44EB-B741-D3C1537A7248 wds:Q68931996-BFA60E73-AF3D-4456-82B6-7B50883D5FD2 wds:Q68931996-F9D48AA2-1FA9-4EF5-8CB4-AEEB4543DECB
author name string	M Konrad R L Comis E C Bradley A R Rudolph R L Krigel K A Padavic-Shaller
rdfs:label	Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon (en) Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon (nl)
skos:prefLabel	Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon (en) Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon (nl)
name	Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon (en) Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon (nl)
title	wds:Q68931996-43D995ED-776B-4E1F-A5B8-58C16B09DFD9
title	Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon (en)
page(s)	wds:Q68931996-1D66E832-E15F-4926-96C1-3817E66BBC35
page(s)	460-467
instance of	wds:Q68931996-257B0636-8831-474D-BC2D-1EBE820E909F
instance of	scholarly article
main subject	wds:Q68931996-2A2D305E-39D6-4D63-9D1D-192A37380CB5
main subject	renal cell carcinoma
PubMed ID	wds:Q68931996-745C1398-58AF-438A-860D-B6CEE27315F8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2407809
PubMed ID	2407809
published in	wds:Q68931996-2E21BD87-3ECE-4643-9B4A-A3A95E887371
published in	Journal of Clinical Oncology
issue	wds:Q68931996-44F4E025-2467-4D06-A865-76CD600988D9
volume	wds:Q68931996-4ED9C4DB-33B9-45FD-8AA7-681F3BAE732F
issue	3
volume	8
DOI	wds:Q68931996-09FF4B9D-57AD-439B-A081-F7C195C538BD
DOI	http://dx.doi.org/10.1200/JCO.1990.8.3.460
DOI	10.1200/JCO.1990.8.3.460
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68931996
is cites work of	Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan Immunotherapy for renal cell carcinoma Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy Interleukin-2 dose, blood monocyte and CD25+ lymphocyte counts as predictors of clinical response to interleukin-2 therapy in patients with renal cell carcinoma Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma. Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival The scientific bases of cancer management: at the interface between fundamental research and clinical practice. Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma The use of interferon in renal cell carcinoma Cancer therapy: reimbursement of new therapeutic technologies Interleukin-2 and interferon in renal cell carcinoma. Phase II Clinical Trial of Recombinant alpha-2 Interferon for Biopsy-proven Metastatic or Recurrent Renal Carcinoma
is cites work of	wds:Q54304195-CCCAA841-4DED-44EF-BC35-4CC1911F9683 wds:Q72873366-BF345639-6B93-4A0B-8E6D-E3928558C6C0 wds:Q33828160-A78439B8-5624-4764-80DB-C49941F522A9 wds:Q61641140-22564CA3-2B0A-4218-946E-C3B2A507ECEB wds:Q36645866-43D30C83-1B66-4E8A-B1C7-6A010E7D7303 wds:Q39998826-C1753960-5B9A-4F72-9DC4-D8D031E661A0 wds:Q36988384-B7F59B66-F167-4AD0-AAE3-4CD6092F8545 wds:Q68193370-9C490104-1CB0-40B6-82CB-AB366D92DB46 wds:Q40384693-A9DC85EA-42AE-42E0-82A6-017909282601 wds:Q36716669-2B1135C8-FBE3-427A-AB22-1A45A5740B51 wds:Q73347788-71D5CC3E-6E06-43ED-B444-243ED5EB1810 wds:Q41827234-2F604497-BB69-42A0-9E86-3CCCA6A2900A wds:Q67801961-645A8D17-79E5-46A3-B63C-077D69311268 wds:Q71321849-B624F6CE-8B3A-4D4E-97B7-24F89D2BBD1F wds:Q35157638-5ED4A44D-7B67-4128-89DA-DCB42B3C491D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software